143 related articles for article (PubMed ID: 31809435)
1. Information Women Choose to Receive About Prenatal Chromosomal Microarray Analysis.
Hochner H; Daum H; Douiev L; Zvi N; Frumkin A; Macarov M; Kimchi-Shaal A; Hacohen N; Eilat A; Faham D; Shkedi-Rafid S
Obstet Gynecol; 2020 Jan; 135(1):149-157. PubMed ID: 31809435
[TBL] [Abstract][Full Text] [Related]
2. Dilemmas in genetic counseling for low-penetrance neuro-susceptibility loci detected on prenatal chromosomal microarray analysis.
Brabbing-Goldstein D; Reches A; Svirsky R; Bar-Shira A; Yaron Y
Am J Obstet Gynecol; 2018 Feb; 218(2):247.e1-247.e12. PubMed ID: 29146387
[TBL] [Abstract][Full Text] [Related]
3. Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study.
Cheng Y; Leung WC; Leung TY; Choy KW; Chiu R; Lo TK; Kwok KY; Sahota DS
BJOG; 2018 Mar; 125(4):451-459. PubMed ID: 29125674
[TBL] [Abstract][Full Text] [Related]
4. Detection of copy number variants with chromosomal microarray in 10 377 pregnancies at a single laboratory.
Lin YH; Jong YJ; Huang PC; Tsai C
Acta Obstet Gynecol Scand; 2020 Jun; 99(6):775-782. PubMed ID: 32346853
[TBL] [Abstract][Full Text] [Related]
5. Personalized prenatal genomic testing: Couples' experience with choice regarding uncertain and adult-onset findings from chromosomal-microarray-analysis.
Millo T; Douiev L; Popper D; Shkedi-Rafid S
Prenat Diagn; 2021 Feb; 41(3):376-383. PubMed ID: 33128404
[TBL] [Abstract][Full Text] [Related]
6. Universal chromosomal microarray analysis reveals high proportion of copy-number variants in low-risk pregnancies.
Stern S; Hacohen N; Meiner V; Yagel S; Zenvirt S; Shkedi-Rafid S; Macarov M; Valsky DV; Porat S; Yanai N; Frumkin A; Daum H
Ultrasound Obstet Gynecol; 2021 May; 57(5):813-820. PubMed ID: 32202684
[TBL] [Abstract][Full Text] [Related]
7. The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis.
Stosic M; Levy B; Wapner R
Obstet Gynecol Clin North Am; 2018 Mar; 45(1):55-68. PubMed ID: 29428286
[TBL] [Abstract][Full Text] [Related]
8. Comparing genetic counselor's and patient's perceptions of needs in prenatal chromosomal microarray testing.
Walser SA; Kellom KS; Palmer SC; Bernhardt BA
Prenat Diagn; 2015 Sep; 35(9):870-8. PubMed ID: 25995037
[TBL] [Abstract][Full Text] [Related]
9. Women's choices for invasive or non-invasive testing: influence of gestational age and service delivery.
Chen A; Tenhunen H; Torkki P; Heinonen S; Lillrank P; Stefanovic V
Prenat Diagn; 2016 Dec; 36(13):1217-1224. PubMed ID: 27859455
[TBL] [Abstract][Full Text] [Related]
10. An exploration of genetic counselors' needs and experiences with prenatal chromosomal microarray testing.
Bernhardt BA; Kellom K; Barbarese A; Faucett WA; Wapner RJ
J Genet Couns; 2014 Dec; 23(6):938-47. PubMed ID: 24569858
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal microarray use among women undergoing invasive prenatal diagnosis.
Naqvi M; Goldfarb IT; Hanmer KJ; Bryant A
Prenat Diagn; 2016 Jul; 36(7):656-61. PubMed ID: 27130707
[TBL] [Abstract][Full Text] [Related]
12. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and mode of inheritance of pathogenic copy number variants in prenatal diagnosis.
Chau MHK; Cao Y; Kwok YKY; Chan S; Chan YM; Wang H; Yang Z; Wong HK; Leung TY; Choy KW
Am J Obstet Gynecol; 2019 Nov; 221(5):493.e1-493.e11. PubMed ID: 31207233
[TBL] [Abstract][Full Text] [Related]
14. Choosing between Higher and Lower Resolution Microarrays: do Pregnant Women Have Sufficient Knowledge to Make Informed Choices Consistent with their Attitude?
van der Steen SL; Bunnik EM; Polak MG; Diderich KEM; Verhagen-Visser J; Govaerts LCP; Joosten M; Knapen MFCM; Go ATJI; Van Opstal D; Srebniak MI; Galjaard RJH; Tibben A; Riedijk SR
J Genet Couns; 2018 Feb; 27(1):85-94. PubMed ID: 28674770
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results.
Pryde PG; Drugan A; Johnson MP; Isada NB; Evans MI
Clin Obstet Gynecol; 1993 Sep; 36(3):496-509. PubMed ID: 8403601
[TBL] [Abstract][Full Text] [Related]
16. Women's experiences receiving abnormal prenatal chromosomal microarray testing results.
Bernhardt BA; Soucier D; Hanson K; Savage MS; Jackson L; Wapner RJ
Genet Med; 2013 Feb; 15(2):139-45. PubMed ID: 22955112
[TBL] [Abstract][Full Text] [Related]
17. Receiving uncertain results from prenatal chromosomal microarray analysis: Women's decisions on continuation or termination of pregnancy.
Libman V; Friedlander Y; Chalk M; Hochner H; Shkedi-Rafid S
Prenat Diagn; 2023 Jun; 43(6):773-780. PubMed ID: 36828779
[TBL] [Abstract][Full Text] [Related]
18. Cut-off value of nuchal translucency as indication for chromosomal microarray analysis.
Maya I; Yacobson S; Kahana S; Yeshaya J; Tenne T; Agmon-Fishman I; Cohen-Vig L; Shohat M; Basel-Vanagaite L; Sharony R
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):332-335. PubMed ID: 28133835
[TBL] [Abstract][Full Text] [Related]
19. Pregnant women's opinions toward prenatal pretest genetic counseling in Japan.
Nishiyama M; Ogawa K; Hasegawa F; Sekido Y; Sasaki A; Akaishi R; Tachibana Y; Umehara N; Wada S; Ozawa N; Sago H
J Hum Genet; 2021 Jul; 66(7):659-669. PubMed ID: 33486503
[TBL] [Abstract][Full Text] [Related]
20. Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing.
McGillivray G; Rosenfeld JA; McKinlay Gardner RJ; Gillam LH
Prenat Diagn; 2012 Apr; 32(4):389-95. PubMed ID: 22467169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
